JSC
Jackson Square Capital’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.27M | Buy |
17,609
+864
| +5% | +$160K | 0.73% | 40 |
|
|
2025
Q1 | $3.51M | Buy |
16,745
+461
| +3% | +$96.6K | 1.14% | 25 |
|
|
2024
Q4 | $2.89M | Sell |
16,284
-9,502
| -37% | -$1.69M | 0.7% | 37 |
|
|
2024
Q3 | $5.09M | Buy |
25,786
+555
| +2% | +$110K | 1.26% | 24 |
|
|
2024
Q2 | $4.33M | Sell |
25,231
-21,672
| -46% | -$3.72M | 1.06% | 29 |
|
|
2024
Q1 | $8.54M | Buy |
46,903
+241
| +0.5% | +$43.9K | 2.2% | 10 |
|
|
2023
Q4 | $7.23M | Sell |
46,662
-1,116
| -2% | -$173K | 2.33% | 11 |
|
|
2023
Q3 | $7.12M | Buy |
47,778
+1,985
| +4% | +$296K | 2.86% | 8 |
|
|
2023
Q2 | $6.17M | Sell |
45,793
-10,671
| -19% | -$1.44M | 2.48% | 7 |
|
|
2023
Q1 | $9M | Buy |
56,464
+14,036
| +33% | +$2.24M | 4.03% | 3 |
|
|
2022
Q4 | $6.86M | Buy |
42,428
+244
| +0.6% | +$39.4K | 3.23% | 4 |
|
|
2022
Q3 | $5.66M | Buy |
42,184
+2,516
| +6% | +$338K | 2.76% | 7 |
|
|
2022
Q2 | $6.08M | Buy |
39,668
+10,558
| +36% | +$1.62M | 2.57% | 8 |
|
|
2022
Q1 | $4.72M | Buy |
29,110
+5,227
| +22% | +$847K | 1.47% | 16 |
|
|
2021
Q4 | $3.23M | Buy |
23,883
+3,608
| +18% | +$489K | 0.93% | 34 |
|
|
2021
Q3 | $2.19M | Buy |
20,275
+3,713
| +22% | +$401K | 0.71% | 44 |
|
|
2021
Q2 | $1.87M | Buy |
16,562
+1,738
| +12% | +$196K | 0.6% | 50 |
|
|
2021
Q1 | $1.6M | Buy |
14,824
+1,740
| +13% | +$188K | 0.61% | 52 |
|
|
2020
Q4 | $1.4M | Sell |
13,084
-10,496
| -45% | -$1.12M | 0.54% | 58 |
|
|
2020
Q3 | $2.07M | Buy |
23,580
+374
| +2% | +$32.8K | 0.91% | 42 |
|
|
2020
Q2 | $2.28M | Buy |
23,206
+22,652
| +4,089% | +$2.22M | 1.15% | 33 |
|
|
2020
Q1 | $42K | Buy |
554
+464
| +516% | +$35.2K | 0.03% | 131 |
|
|
2019
Q4 | $8K | Buy |
+90
| New | +$8K | ﹤0.01% | 270 |
|